Barclays’s Applied Therapeutics APLT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3K | Sell |
11,103
-117,981
| -91% | -$31.9K | ﹤0.01% | 4238 |
|
|
2025
Q1 | $63K | Sell |
129,084
-42,931
| -25% | -$21K | ﹤0.01% | 3834 |
|
|
2024
Q4 | $147K | Sell |
172,015
-27,997
| -14% | -$23.9K | ﹤0.01% | 3654 |
|
|
2024
Q3 | $1.7M | Buy |
200,012
+130,102
| +186% | +$1.11M | ﹤0.01% | 2298 |
|
|
2024
Q2 | $326K | Buy |
69,910
+8,638
| +14% | +$40.3K | ﹤0.01% | 2777 |
|
|
2024
Q1 | $417K | Buy |
+61,272
| New | +$417K | ﹤0.01% | 2938 |
|
|
2023
Q3 | – | Sell |
-232
| Closed | – | – | 4243 |
|
|
2023
Q2 | $0 | Buy |
232
+221
| +2,009% | – | ﹤0.01% | 4239 |
|
|
2023
Q1 | $0 | Buy |
+11
| New | – | ﹤0.01% | 4291 |
|
|
2022
Q3 | – | Sell |
-1
| Closed | – | – | 4625 |
|
|
2022
Q2 | $0 | Sell |
1
-3,987
| -100% | – | ﹤0.01% | 4691 |
|
|
2022
Q1 | $8K | Sell |
3,988
-17,510
| -81% | -$35.1K | ﹤0.01% | 4508 |
|
|
2021
Q4 | $193K | Buy |
21,498
+3,582
| +20% | +$32.2K | ﹤0.01% | 2843 |
|
|
2021
Q3 | $298K | Buy |
17,916
+15,586
| +669% | +$259K | ﹤0.01% | 2808 |
|
|
2021
Q2 | $49K | Sell |
2,330
-10,725
| -82% | -$226K | ﹤0.01% | 3397 |
|
|
2021
Q1 | $244K | Buy |
13,055
+8,658
| +197% | +$162K | ﹤0.01% | 3044 |
|
|
2020
Q4 | $97K | Sell |
4,397
-1,839
| -29% | -$40.6K | ﹤0.01% | 2984 |
|
|
2020
Q3 | $129K | Sell |
6,236
-9,887
| -61% | -$205K | ﹤0.01% | 2926 |
|
|
2020
Q2 | $584K | Sell |
16,123
-8,650
| -35% | -$313K | ﹤0.01% | 2245 |
|
|
2020
Q1 | $810K | Buy |
24,773
+3,308
| +15% | +$108K | ﹤0.01% | 1862 |
|
|
2019
Q4 | $586K | Buy |
21,465
+20,470
| +2,057% | +$559K | ﹤0.01% | 2604 |
|
|
2019
Q3 | $11K | Buy |
+995
| New | +$11K | ﹤0.01% | 3895 |
|